Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study.

Spoto B, Kakkar R, Lo L, Devalaraja M, Pizzini P, Torino C, Leonardis D, Cutrupi S, Tripepi G, Mallamaci F, Zoccali C.

J Clin Med. 2019 Apr 16;8(4). pii: E523. doi: 10.3390/jcm8040523.

2.

Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study.

Zoccali C, D'Arrigo G, Leonardis D, Pizzini P, Postorino M, Tripepi G, Mallamaci F.

J Hypertens. 2019 Jul;37(7):1359-1365. doi: 10.1097/HJH.0000000000002030.

PMID:
30633126
3.

Wearable Haptics and Immersive Virtual Reality Rehabilitation Training in Children With Neuromotor Impairments.

Bortone I, Leonardis D, Mastronicola N, Crecchi A, Bonfiglio L, Procopio C, Solazzi M, Frisoli A.

IEEE Trans Neural Syst Rehabil Eng. 2018 Jul;26(7):1469-1478. doi: 10.1109/TNSRE.2018.2846814.

PMID:
29985156
4.

Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.

Brück K, Jager KJ, Zoccali C, Bello AK, Minutolo R, Ioannou K, Verbeke F, Völzke H, Arnlöv J, Leonardis D, Ferraro PM, Brenner H, Caplin B, Kalra PA, Wanner C, Castelao AM, Gorriz JL, Hallan S, Rothenbacher D, Gibertoni D, De Nicola L, Heinze G, Van Biesen W, Stel VS; European CKD Burden Consortium.

Kidney Int. 2018 Jun;93(6):1432-1441. doi: 10.1016/j.kint.2018.01.008. Epub 2018 Apr 12.

PMID:
29656901
5.

Neuropeptide Y and chronic kidney disease progression: a cohort study.

Zoccali C, D'Arrigo G, Leonardis D, Pizzini P, Postorino M, Tripepi G, Mallamaci F, van den Brand J, van Zuilen A, Wetzels J, Bots ML, Blankestijn P.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1805-1812. doi: 10.1093/ndt/gfx351.

PMID:
29370406
6.

Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients.

Mallamaci F, D'Arrigo G, Tripepi R, Leonardis D, Porto G, Testa A, Abd ElHafeez S, Mafrica A, Versace MC, Provenzano PF, Tripepi G, Mancini P, Zoccali C.

J Hypertens. 2018 Jan;36(1):119-125. doi: 10.1097/HJH.0000000000001530.

PMID:
28858982
7.

Integration of serious games and wearable haptic interfaces for Neuro Rehabilitation of children with movement disorders: A feasibility study.

Bortone I, Leonardis D, Solazzi M, Procopio C, Crecchi A, Bonfiglio L, Frisoli A.

IEEE Int Conf Rehabil Robot. 2017 Jul;2017:1094-1099. doi: 10.1109/ICORR.2017.8009395.

PMID:
28813967
8.

Effects of Continuous Kinaesthetic Feedback Based on Tendon Vibration on Motor Imagery BCI Performance.

Barsotti M, Leonardis D, Vanello N, Bergamasco M, Frisoli A.

IEEE Trans Neural Syst Rehabil Eng. 2018 Jan;26(1):105-114. doi: 10.1109/TNSRE.2017.2739244. Epub 2017 Aug 14.

PMID:
28809705
9.

A 3-RSR Haptic Wearable Device for Rendering Fingertip Contact Forces.

Leonardis D, Solazzi M, Bortone I, Frisoli A.

IEEE Trans Haptics. 2017 Jul-Sep;10(3):305-316. doi: 10.1109/TOH.2016.2640291. Epub 2016 Dec 15.

PMID:
28113306
10.

Local and Remote Cooperation With Virtual and Robotic Agents: A P300 BCI Study in Healthy and People Living With Spinal Cord Injury.

Tidoni E, Abu-Alqumsan M, Leonardis D, Kapeller C, Fusco G, Guger C, Hintermuller C, Peer A, Frisoli A, Tecchia F, Bergamasco M, Aglioti SM.

IEEE Trans Neural Syst Rehabil Eng. 2017 Sep;25(9):1622-1632. doi: 10.1109/TNSRE.2016.2626391. Epub 2016 Dec 23.

PMID:
28026777
11.

[Cervical cancer screening with primary HPV-DNA test in the Local Health Authority 2 of Savona (Liguria Region, Northern Italy): a population-based study].

Depetrini E, Bonelli L, Ardoino S, Cirucca MC, Contin R, De Leonardis D, Errigo V, Lugani A, Franco A, Pastorino A, Carrozzi G, Venturino E.

Epidemiol Prev. 2016 Mar-Apr;40(3-4):171-8. doi: 10.19191/EP16.3-4.AD04.078. Italian.

12.

A polymorphism in a major antioxidant gene (Kelch-like ECH-associated protein 1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study.

Testa A, Leonardis D, Spoto B, Sanguedolce MC, Parlongo RM, Pisano A, Tripepi G, Mallamaci F, Zoccali C.

J Hypertens. 2016 May;34(5):928-34. doi: 10.1097/HJH.0000000000000878.

PMID:
26974313
13.

Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients.

Mallamaci F, Tripepi R, Leonardis D, Mafrica A, Versace MC, Provenzano F, Tripepi G, Zoccali C.

Transplantation. 2016 Oct;100(10):2211-8. doi: 10.1097/TP.0000000000001023.

PMID:
26683511
14.

A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients.

Testa A, Prudente S, Leonardis D, Spoto B, Sanguedolce MC, Parlongo RM, Tripepi G, Rizza S, Mallamaci F, Federici M, Trischitta V, Zoccali C.

Nutr Metab Cardiovasc Dis. 2015 Dec;25(12):1087-94. doi: 10.1016/j.numecd.2015.08.004. Epub 2015 Aug 21. Review.

PMID:
26607700
15.

Epidemiology of CKD Regression in Patients under Nephrology Care.

Borrelli S, Leonardis D, Minutolo R, Chiodini P, De Nicola L, Esposito C, Mallamaci F, Zoccali C, Conte G.

PLoS One. 2015 Oct 13;10(10):e0140138. doi: 10.1371/journal.pone.0140138. eCollection 2015.

16.

An EMG-Controlled Robotic Hand Exoskeleton for Bilateral Rehabilitation.

Leonardis D, Barsotti M, Loconsole C, Solazzi M, Troncossi M, Mazzotti C, Castelli VP, Procopio C, Lamola G, Chisari C, Bergamasco M, Frisoli A.

IEEE Trans Haptics. 2015 Apr-Jun;8(2):140-51. doi: 10.1109/TOH.2015.2417570. Epub 2015 Mar 30.

PMID:
25838528
17.

High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease.

Bolignano D, Lennartz S, Leonardis D, D'Arrigo G, Tripepi R, Emrich IE, Mallamaci F, Fliser D, Heine G, Zoccali C.

Kidney Int. 2015 Jul;88(1):130-6. doi: 10.1038/ki.2015.27. Epub 2015 Feb 18.

PMID:
25692957
18.

Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.

Spoto B, Mattace-Raso F, Sijbrands E, Leonardis D, Testa A, Pisano A, Pizzini P, Cutrupi S, Parlongo RM, D'Arrigo G, Tripepi G, Mallamaci F, Zoccali C.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):232-40. doi: 10.2215/CJN.07000714. Epub 2014 Dec 9.

19.

Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.

Testa A, Mallamaci F, Leonardis D, Spoto B, Pisano A, Sanguedolce MC, Tripepi G, Zoccali C; MAURO Study Investigators.

Nutr Metab Cardiovasc Dis. 2015 Feb;25(2):167-72. doi: 10.1016/j.numecd.2014.10.016. Epub 2014 Nov 6.

PMID:
25435339
20.

A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based study.

Mallamaci F, Testa A, Leonardis D, Tripepi R, Pisano A, Spoto B, Sanguedolce MC, Parlongo RM, Tripepi G, Zoccali C.

Am J Kidney Dis. 2015 Feb;65(2):294-302. doi: 10.1053/j.ajkd.2014.07.021. Epub 2014 Oct 7.

PMID:
25301104
21.

Illusory movements induced by tendon vibration in right- and left-handed people.

Tidoni E, Fusco G, Leonardis D, Frisoli A, Bergamasco M, Aglioti SM.

Exp Brain Res. 2015 Feb;233(2):375-83. doi: 10.1007/s00221-014-4121-8. Epub 2014 Oct 8.

PMID:
25294499
22.

Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.

Tripepi G, Kollerits B, Leonardis D, Yilmaz MI, Postorino M, Fliser D, Mallamaci F, Kronenberg F, Zoccali C.

J Am Soc Nephrol. 2015 Apr;26(4):935-44. doi: 10.1681/ASN.2013121355. Epub 2014 Aug 22.

23.

A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study.

Mallamaci F, Testa A, Leonardis D, Tripepi R, Pisano A, Spoto B, Sanguedolce MC, Parlongo RM, Tripepi G, Zoccali C.

J Hypertens. 2014 Aug;32(8):1621-8; discussion 1628. doi: 10.1097/HJH.0000000000000224. Erratum in: J Hypertens. 2014 Dec;32(12):2504.

PMID:
24805955
24.

Association of a polymorphism in a gene encoding a urate transporter with CKD progression.

Testa A, Mallamaci F, Spoto B, Pisano A, Sanguedolce MC, Tripepi G, Leonardis D, Zoccali C.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1059-65. doi: 10.2215/CJN.11041013. Epub 2014 Apr 17.

25.

Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial.

Mallamaci F, Leonardis D, Pizzini P, Cutrupi S, Tripepi G, Zoccali C.

J Hypertens. 2013 Jul;31(7):1424-30; discussion 1430. doi: 10.1097/HJH.0b013e328360ddd5.

PMID:
23743803
26.

Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.

Mallamaci F, Minutolo R, Leonardis D, D'Arrigo G, Tripepi G, Rapisarda F, Cicchetti T, Maimone I, Enia G, Postorino M, Santoro D, Fuiano G, De Nicola L, Conte G, Zoccali C.

Kidney Int. 2013 Aug;84(2):381-9. doi: 10.1038/ki.2013.132. Epub 2013 Apr 24.

27.

The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity.

Spoto B, Mattace-Raso F, Sijbrands E, Mallamaci F, Leonardis D, Aucella F, Testa A, Gesuete A, Sanguedolce MC, D'Arrigo G, Parlongo RM, Pisano A, Torino C, Enia G, Tripepi G, Postorino M, Zoccali C.

Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv58-62. doi: 10.1093/ndt/gfs550.

PMID:
23258813
28.

The MAURO study: baseline characteristics and compliance with guidelines targets.

Leonardis D, Mallamaci F, Enia G, Postorino M, Tripepi G, Zoccali C; MAURO Study Investigators.

J Nephrol. 2012 Nov-Dec;25(6):1081-90. doi: 10.5301/jn.5000239.

PMID:
23172127
29.

Heart rate, age and the risk of progression to kidney failure in patients with CKD.

Zoccali C, Leonardis D, Enia G, Postorino M, D'Arrigo G, Tripepi G, Mallamaci F; MAURO Study Investigators.

J Nephrol. 2012;25 Suppl 19:S20-7. doi: 10.5301/jn.5000229.

PMID:
23032914
30.

Enamel matrix derivative, alone or associated with a synthetic bone substitute, in the treatment of 1- to 2-wall periodontal defects.

De Leonardis D, Paolantonio M.

J Periodontol. 2013 Apr;84(4):444-55. doi: 10.1902/jop.2012.110656. Epub 2012 May 21.

PMID:
22612371
31.

Preliminary results of BRAVO project: brain computer interfaces for Robotic enhanced Action in Visuo-motOr tasks.

Bergamasco M, Frisoli A, Fontana M, Loconsole C, Leonardis D, Troncossi M, Foumashi MM, Parenti-Castelli V.

IEEE Int Conf Rehabil Robot. 2011;2011:5975377. doi: 10.1109/ICORR.2011.5975377.

PMID:
22275581
32.

Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients.

Spoto B, Leonardis D, Parlongo RM, Pizzini P, Pisano A, Cutrupi S, Testa A, Tripepi G, Zoccali C, Mallamaci F.

Nutr Metab Cardiovasc Dis. 2012 Nov;22(11):981-8. doi: 10.1016/j.numecd.2011.01.005. Epub 2011 Sep 8.

PMID:
21906921
33.

Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition.

Zoccali C, Ruggenenti P, Perna A, Leonardis D, Tripepi R, Tripepi G, Mallamaci F, Remuzzi G; REIN Study Group.

J Am Soc Nephrol. 2011 Oct;22(10):1923-30. doi: 10.1681/ASN.2011020175. Epub 2011 Aug 18.

34.

ACE inhibition is renoprotective among obese patients with proteinuria.

Mallamaci F, Ruggenenti P, Perna A, Leonardis D, Tripepi R, Tripepi G, Remuzzi G, Zoccali C; REIN Study Group.

J Am Soc Nephrol. 2011 Jun;22(6):1122-8. doi: 10.1681/ASN.2010090969. Epub 2011 Apr 28.

35.

Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).

Leonardis D, Basta G, Mallamaci F, Cutrupi S, Pizzini P, Tripepi R, Tripepi G, De Caterina R, Zoccali C.

Nutr Metab Cardiovasc Dis. 2012 Sep;22(9):748-55. doi: 10.1016/j.numecd.2010.11.008. Epub 2011 Apr 5.

PMID:
21470837
36.

Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease.

Basta G, Leonardis D, Mallamaci F, Cutrupi S, Pizzini P, Gaetano L, Tripepi R, Tripepi G, De Caterina R, Zoccali C.

Kidney Int. 2010 Feb;77(3):225-31. doi: 10.1038/ki.2009.419. Epub 2009 Nov 18.

37.

Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients.

Stancanelli B, Malatino LS, Cataliotti A, Bellanuova I, Mallamaci F, Tripepi G, Benedetto FA, Leonardis D, Fatuzzo P, Rapisarda F, Zoccali C.

Nephron Clin Pract. 2010;114(1):c74-80. doi: 10.1159/000252806. Epub 2009 Oct 23.

PMID:
19851079
38.

Sleep disordered breathing in renal transplant patients.

Mallamaci F, Leonardis D, Tripepi R, Parlongo G, Catalano C, Tripepi G, Castronovo V, Ferini-Strambi L, Zoccali C.

Am J Transplant. 2009 Jun;9(6):1373-81. doi: 10.1111/j.1600-6143.2009.02653.x. Epub 2009 May 20.

39.

[Measuring the glomerular filtrate rate: calibration and formulas].

Leonardis D.

G Ital Nefrol. 2008 Nov-Dec;25(6):611. Italian. No abstract available.

PMID:
19048551
40.

The MAURO study: multiple intervention and audit in renal diseases to optimize care.

Zoccali C, Leonardis D, Enia G, Postorino M, Mallamaci F; MAURO study working group.

J Nephrol. 2008 Jan-Feb;21(1):20-2. No abstract available.

PMID:
18264932
41.

Circulating E-selectin as a risk marker in patients with end-stage renal disease.

Malatino LS, Stancanelli B, Cataliotti A, Bellanuova I, Fatuzzo P, Rapisarda F, Leonardis D, Tripepi G, Mallamaci F, Zoccali C.

J Intern Med. 2007 Oct;262(4):479-87.

42.

Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function.

Addabbo F, Mallamaci F, Leonardis D, Tripepi R, Tripepi G, Goligorsky MS, Zoccali C.

Nephrol Dial Transplant. 2007 Dec;22(12):3521-6. Epub 2007 Jul 17.

PMID:
17636056
43.

Gene symbol: msh2. Disease: hereditary nonpolyposis colorectal cancer.

Leonardis D.

Hum Genet. 2006 Jul;119(6):675. No abstract available.

PMID:
17128465
44.

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, Lesti M, Perticucci E, Chakarski IN, Leonardis D, Garini G, Sessa A, Basile C, Alpa M, Scanziani R, Sorba G, Zoccali C, Remuzzi G; REIN-2 Study Group.

Lancet. 2005 Mar 12-18;365(9463):939-46.

PMID:
15766995
45.

The use of calcium sulphate in the surgical treatment of a 'through and through' periradicular lesion.

Pecora G, De Leonardis D, Ibrahim N, Bovi M, Cornelini R.

Int Endod J. 2001 Apr;34(3):189-97.

PMID:
12193264
46.

Relationship of parent driving records to the driving records of their children.

Ferguson SA, Williams AF, Chapline JF, Reinfurt DW, De Leonardis DM.

Accid Anal Prev. 2001 Mar;33(2):229-34.

PMID:
11204894
47.
48.

Augmentation of the maxillary sinus with calcium sulfate: one-year clinical report from a prospective longitudinal study.

De Leonardis D, Pecora GE.

Int J Oral Maxillofac Implants. 1999 Nov-Dec;14(6):869-78.

PMID:
10612926
49.

Osseointegration of rough acid-etched titanium implants: 5-year follow-up of 100 minimatic implants.

De Leonardis D, Garg AK, Pecora GE.

Int J Oral Maxillofac Implants. 1999 May-Jun;14(3):384-91.

PMID:
10379112
50.

Source memory and eyewitness suggestibility in older adults.

Multhaup KS, De Leonardis DM, Johnson MK.

J Gen Psychol. 1999 Jan;126(1):74-84.

PMID:
10216970

Supplemental Content

Loading ...
Support Center